Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

NCT00353015

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +13 more
Locations: U.T. M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

NCT00527761

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

E7070 in Treating Patients With Stage IV Melanoma

NCT00014625

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Kaiser Franz Josef Hospital Vienna, Austria

Institut Jules Bordet Brussels, Belgium

Centre Jean Perrin Clermont-Ferrand, France

Centre Leon Berard Lyon, France

View Trial Details

Completed

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

NCT00002764

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +62 more
Locations: Lund University Hospital Lund, Sweden

View Trial Details

Completed

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

NCT00003989

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Universitaetsklinik Innsbruck, Austria

Kaiser Franz Josef Hospital Vienna (Wien), Austria

Institut Jules Bordet Brussels (Bruxelles), Belgium

Ludwig Institute for Cancer Research-Brussels Branch Brussels (Bruxelles), Belgium

View all 27 locations

View Trial Details

Completed

Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery

NCT00438087

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +26 more
Locations: Assistance Publique Hopitaux de Paris Clichy, France

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

NCT00023647

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

View Trial Details

Completed

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

NCT00257205

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Research Site Huntsville, Alabama, United States

Research Site Mobile, Alabama, United States

Research Site Scottsdale, Arizona, United States

Research Site Little Rock, Arkansas, United States

View all 143 locations

View Trial Details

Completed

Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00002669

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Landeskrankenanstalten - Salzburg Salzburg, Austria

Hopital Universitaire Erasme Brussels, Belgium

Institut Jules Bordet Brussels (Bruxelles), Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View all 24 locations

View Trial Details

Completed

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

NCT00094107

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Pfizer Investigational Site Orange, California, United States

Pfizer Investigational Site Miami Beach, Florida, United States

Pfizer Investigational Site Boston, Massachusetts, United States

Pfizer Investigational Site Boston, Massachusetts, United States

View Trial Details